Table 1.
Prevalence of HAV immunity by sociodemographic characteristics for All HIV-infected patients, men who have sex with men or persons who inject drugs, medical monitoring project, United States, 2009–2012.
| Characteristic | Overall (N = 18,095) |
MSM or PWID (N = 8678) |
||||||
|---|---|---|---|---|---|---|---|---|
| Immune |
Not immune |
Immune |
Not immune |
|||||
| n | % (95% CI) | n | % (95% CI) | n | % (95% CI) | n | % (95% CI) | |
| Total | 11,208 | 62 (59–65) | 6887 | 38 (35–41) | 5595 | 64 (61–68) | 3083 | 36 (32–39) |
| Gender | ||||||||
| Male | 8280 | 76 (73–78) | 4780 | 70 (68–73) | 5562 | 99 (99–100) | 3063 | 99 (99–100) |
| Female | 2762 | 24 (22–27) | 2018 | 30 (27–32) | 29 | 0.4 (0.2–0.6) | 18 | 0.5 (0.3–0.8) |
| Sexual orientation | ||||||||
| Heterosexual or straight | 5323 | 47 (42–51) | 3601 | 51 (47–55) | 146 | 2 (1–3) | 71 | 2 (1–3) |
| Homosexual or gay | 4748 | 43 (39–48) | 2672 | 40 (36–44) | 4604 | 83 (81–85) | 2584 | 84 (82–86) |
| Bisexual | 977 | 9 (8–9) | 516 | 8 (7–8) | 791 | 14 (12–16) | 403 | 13 (12–15) |
| Other | 160 | 2 (1–2) | 98 | 1 (1–2) | 54 | 1 (0.7–1.4) | 25 | 1 (1–1) |
| Age | ||||||||
| 18–29 | 857 | 8 (7–9) | 486 | 7 (6–8) | 530 | 10 (8–11) | 249 | 8 (7–10) |
| 30–39 | 1795 | 16 (15–17) | 1046 | 15 (14–16) | 947 | 17 (16–19) | 473 | 15 (14–17) |
| 40–49 | 3969 | 35 (34–36) | 2427 | 35 (33–36) | 2050 | 36 (35–38) | 1116 | 36 (34–38) |
| ≥50 | 4587 | 40 (39–42) | 2928 | 43 (41–44) | 2068 | 37 (35–39) | 1245 | 40 (38–42) |
| Race/ethnicity | ||||||||
| White, non-Hispanic | 3660 | 34 (29–40) | 2234 | 35 (29–39) | 2779 | 51 (45–57) | 1585 | 53 (47–58) |
| Black, non-Hispanic | 4677 | 42 (34548) | 2799 | 41 (34–48) | 1386 | 24 (19–29) | 728 | 24 (20–29) |
| Hispanic or Latino | 2307 | 19 (16–22) | 1583 | 20 (14–26) | 110 | 19 (16–21) | 640 | 18 (14–23) |
| Other | 564 | 5 (4–6) | 271 | 4 (3–5) | 343 | 6 (5–7) | 134 | 5 (4–6) |
| Education | ||||||||
| <High school | 2461 | 21 (19–23) | 1515 | 21 (19–23) | 524 | 9 (8–10) | 266 | 9 (7–10) |
| High school diploma or equivalent | 3063 | 27 (25–29) | 1872 | 27 (25–29) | 1226 | 22 (20−23) | 639 | 21 (19–23) |
| >High school | 5681 | 52 (49–55) | 3496 | 52 (49–55) | 3844 | 69 (67–71) | 2177 | 71 (68–73) |
| Country or territory of birth | ||||||||
| Born in foreign country | 1556 | 14 (12–16) | 836 | 12 (11–14) | 738 | 14 (12–15) | 352 | 11 (9–13) |
| Born in US or PR | 9647 | 86 (84–88) | 6049 | 88 (86–89) | 4855 | 86 (85–88) | 2731 | 89 (87–91) |
| Homeless (past 12 months) | ||||||||
| Yes | 1028 | 9 (8–10) | 492 | 7 (6–8) | 410 | 7 (6–8) | 184 | 6 (5–7) |
| No | 10,178 | 91 (91–92) | 6394 | 93 (92–94) | 5185 | 93 (92–94) | 2899 | 94 (93–95) |
| Time since HIV diagnosis (yr.) | ||||||||
| <5 years | 2383 | 22 (21–24) | 1404 | 22 (20–23) | 1261 | 24 (23–25) | 626 | 21 (19–23) |
| ≥5 years | 8822 | 78 (76–79) | 5476 | 78 (77–80) | 4332 | 76 (75–78) | 2454 | 79 (77–81) |
| Received STD screening | ||||||||
| Yes | 7725 | 67 (63–70) | 3620 | 50 (47–52) | 3875 | 68 (65–71) | 1646 | 52 (49–55) |
| No | 3424 | 33 (30–37) | 3193 | 50 (48–53) | 1682 | 32 (29–35) | 1397 | 48 (45–51) |
| Hepatitis C screening | ||||||||
| Yes | 9652 | 85 (84–86) | 4207 | 59 (56–61) | 4753 | 85 (83–86) | 1724 | 54 (52–57) |
| No | 1556 | 15 (14–16) | 2680 | 41 (39–44) | 842 | 15 (14–17) | 1359 | 46 (43–48) |
HAV, hepatitis A virus; CI, confidence interval; MSM, men who have sex with men; PWID, persons who inject drugs; PR, Puerto Rico; STD, sexually transmitted disease.